HF
TENX icon

HRT Financial’s Tenax Therapeutics TENX Stock Holding History

HRT Financial’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,819
Closed -$534K – 5320
2026
Q1 		$668K Buy
+41,819
New +$566K ﹤0.01% 2324
2024
Q1 		– Sell
-260
Closed -$5K – 3074
2023
Q4 		$5K Buy
+260
New +$6.24K ﹤0.01% 2133
2023
Q3 		– Sell
-145
Closed -$3K – 3084
2023
Q2 		$3K Buy
+145
New +$3.87K ﹤0.01% 2266
2023
Q1 		– Sell
-16
Closed -$2K – 3184
2022
Q4 		$2K Buy
16
+5
+45% +$1.1K ﹤0.01% 2335
2022
Q3 		$2K Buy
+11
New +$4.41K ﹤0.01% 2652
2022
Q2 		– Sell
-7
Closed -$8K – 3714
2022
Q1 		$8K Sell
7
-1
-13% -$1.11K ﹤0.01% 2919
2021
Q4 		$13K Buy
+8
New +$18K ﹤0.01% 2999
2020
Q3 		– Sell
-13
Closed -$18K – 2337
2020
Q2 		$18K Buy
+13
New +$19.1K ﹤0.01% 1433

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

HRT Financial's TENX Position: Q2 2026 in Review

HRT Financial sold out of Tenax Therapeutics (TENX) in Q2 2026, closing a stake of 41,819 shares — an estimated $534K sold.

HRT Financial first reported a position in TENX in Q2 2020 and held it in 8 quarters. The position peaked at $668K in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • HRT Financial reported no remaining Tenax Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 41,819 Tenax Therapeutics shares in Q2 2026, an estimated $534K.
  • HRT Financial first reported a position in Tenax Therapeutics in Q2 2020 and held it in 8 quarters.
  • HRT Financial's Tenax Therapeutics position peaked at $668K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.